Rigel Pharma (RIGL) Tops Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $35.73 +8.57%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
JFIN, KEQU, LASE, More
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of $0.04, $0.12 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $26.89 million versus the consensus estimate of $25.7 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
